Clinical onset of CNS demyelinating disease after COVID-19 vaccination: denovo disease?

BACKGROUND: Clinical onset of multiple sclerosis (MS(postvacc)) and myelin-oligodendrocyte-glycoprotein-antibody-associated disease (MOGAD(postvacc)) has been reported in association with SARS-CoV-2-vaccination. There is uncertainty as to whether this is causality (denovo disease) or temporal coinci...

Descripción completa

Detalles Bibliográficos
Autores principales: Gernert, J.A., Zimmermann, H., Oswald, E., Christmann, T., Kümpfel, T., Havla, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464312/
https://www.ncbi.nlm.nih.gov/pubmed/36126540
http://dx.doi.org/10.1016/j.msard.2022.104175

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464312/
https://www.ncbi.nlm.nih.gov/pubmed/36126540
http://dx.doi.org/10.1016/j.msard.2022.104175

Ejemplares similares